Protective effect of speman on cisplatin-induced testicular and epididymal toxicity in mice
DOI:
https://doi.org/10.22377/ijgp.v5i4.215Abstract
Testicular cancer is the most common cancer affecting men of reproductive age. Advances in treatment of the disease, which includes the administration of cisplatin, have brought the 5-year survival rate to over 90%. This high cure rate, coupled with young age of patients, makes elucidation of the impact of the treatment on reproduction become increasingly important. The objective of the present study was to investigate the protective effect of speman, a non-hormonal herbal formulation, on cisplatin-induced suppressed male reproductive health in mice. Male mice were treated with cisplatin or speman alone or in combination and assessed for spermatogenesisand steroidogenesis. Significant decrease in the weights of testes and epididymis was observed in cisplatin treated animals. Injection of cisplatin significantly decreased epididymal sperm count, viable sperms, motile sperms and hypo-osmotic swelling (HOS)-tail coiled sperms with a significant reduction in the testicular steroidogenic enzyme activities and serum testosterone levels, whereas co-administration of speman with cisplatin showed a significant improvement in the selected reproductive parameters over cisplatin alone treated mice indicating the beneficial effect of speman to combat cisplatin-induced suppressed reproduction in male mice.
Key words: Cisplatin, male mice, speman, sperm, steroidogenesis
Downloads
References
Bergström R, Adami HO, Möhner M, Zatonski W, Storm H,
Ekbom A, et al. Increase in testicular cancer incidence in six
European countries: A birth cohort phenomenon. J Natl Cancer
Inst 1996;88:727-33
Lebwohl D, Canetta R. Clinical development of platinum
complexes in cancer therapy: An historical perspective and an
update. Eur J Cancer 1998;34:1522-34.
Taguchi T, Nazneen A, Abid MR, Razzaque MS. Cisplatinassociated
nephrotoxicity and pathological events. Contrib
Nephrol 2005;148:107-21.
Stephenson WT, Poirier SM, Rubin L, Einhorn LH. Evaluation
of reproductive capacity in germ cell tumor patients following
treatment with cisplatin, etoposide, and bleomycin. J Clin Oncol
;13:2278-80.
Zhang X, Yamamoto N, Soramoto S, Takenaka I. Cisplatin-induced
germ cell apoptosis in mouse testes. Arch Androl 2001;46:43-9.
Vawda AI. Effect of testosterone on cisplatin-induced testicular
damage. Arch Androl 1994;32:53-7.
Malarvizhi D, Mathur PP. Effect of cisplatin on testicular function
in rats. Indian J Exp Biol 1996;34:995-8.
Narayana K. Cisplatin induces duplex 3’ overhangs and 5’ blunt
ends in epididymal epithelium in a Bax-dependent manner
without any protection from L-ascorbic acid. Eur J Pharmacol
;641:238-45.
Ali BH, Al Moundhri MS. Agents ameliorating or augmenting the
nephrotoxicity of cisplatin and other platinum compounds: A reviewof some recent research. Food Chem Toxicol 2006;44:1173-83.
Mukherjee K, Tripathi A, Kulkarni KS. Evaluation of the efficacy
of ‘Speman’ in the management of male subfertility. Indian J Clin
Pract 2003;13:29-31.
Sahu KC. Clinical observations on the use of speman in the
treatment of spermatorrhoea. Med Digest 1954;9:485.
Mukherjee M, Rai DK, Dubey GP. Testicular changes in
electroshock-induced stress and effect of Speman. Probe
;29:300-6.
Mathur R, Kulshrestha R. Restitution of ceric sulphate-induced
sterility in rats by zinc and Speman. J Sci Res 1984;6:11-4.
Rathore HS. Protection of mouse testes, epididymis and adrenals
with Speman against cadmimum intoxication. Med Surg
:26:33-5.
Bhan A, Rathore H. Prevention of Hexachlorocyclohexane (HCH)-
induced changes in selected reproductive organs of mice with a
herbal drug speman in acute exposure. Indian J Occup Health
;39:1-7.
CPCSEA (Committee for the Purpose of Control and Supervision
on Experiments on Animals) CPCSEA guidelines for laboratory
animal facility. Indian J Pharmacol 2003;35:257-74.
NRC (National Research Council). Guide for the care and use
of laboratory animals. Institute of Laboratory Animal Resources
(ILAR), Commission on Life Sciences. Washington, DC: National
Academy Press; 1996. p. 125.
Mclaren A. Germ cells and germ cell transplantation. Int J Dev
Biol 1998;42:855-60.
Subbarao VV, Gupta ML, Arora HL. Effect of Speman on the testes.
Probe 1973:12:197-200.
Belsey MA, Moghissi KS, Eliasson R, Paulsen CA, Callegos AJ,
Prasad MR. Laboratory manual for the examination of human
semen and semen-cervical mucus interaction. Singapore: Press
concern. 1980. p. 10.
Talbot P, Chacon RS. A triple stain technique for evaluating
normal acrosome reaction of human sperm. J Exp Zool 1981;215:
-8.
Jeyendran RS, Van der Ven HH, Zaneveld LJ. The hypoosmotic
swelling test: An update. Arch Androl 1992;29:105-16.
Bergmayer HU. Methods of enzymatic analysis. In: Bergmayer HU,
editor. Verlag Chemie Weinheim, New York: Academic Press; 1974.
p. 447-89.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein
measurement with the Folin phenol reagent. J Biol Chem
;193:265-75.
Rao AJ, Chakraborti R, Kotagi SG, Ravindranath N. Effect of
constant infusion of gonadotropin releasing hormone (GnRH)
agonist buserelin and antagonist CDB 2085 A using osmotic
minipumps on testicular function in adult male bonnet monkey
(Macaca radiata). Andrologia 1990;22:567-73.
Bieber AM, Marcon L, Hales BF, Robaire B. Effects of
chemotherapeutic agents for testicular cancer on the male
reproductive system, spermatozoa, and fertility. J Androl
;27:189-200
Schlappack OK, Kratzik C, Schmidt W, Spona J, Schuster E.
Response of seminiferous epithelium to scattered radiation in
seminoma patients. Cancer 1988;62:1487-91.
Jayatilak PG, Pardanani DS, Dattatreya B, Sheth AR. Effect of an
indigenous drug (Speman) on accessory reproductive functions
of mice. Ind J Exp Biol 1976;14:170-3.
Ohl DA, Menge AC, Sonksen J. Penile vibratory stimulation in
spinal cord injured men: Optimized vibration parameters and
prognostic factors. Arch Phys Med Rehabil 1996;77:903-5.
Seethalakshmi L, Flores C, Kinkead T, Carboni AA, Malhotra RK,
Menon M. Effects of subchronic treatment with cis-platinum
on testicular function, fertility, progeny outcome, and progeny.
J Androl 1992;13:65-74.
Azu OO, Duru FI, Osinubi AA, Oremosu AA, Norohna CC,
Okanlawon AO. Long-term treatment with Kigelia africana fruit extract
ameliorates the testicular toxicity following cisplatin administration
in male Sprague-Dawley rats. Eur J Pharmacol 2010;641:238-45.
Schrader M, Muller M, Straub B, Miller K. Testicular sperm
extraction in azoospermic patients with gonadal germ cell tumours
prior to chemotherapy-a new therapy option. Asian J Androl
;4:9-15.
Seaman F, Sawhney E, Giammona CJ, Richburg JH. Cisplatininduced
pulse of germ cell apoptosis precedes long-term elevated
apoptotic rates in C57/BL/6 mouse testis. Apoptosis 2003;8:101-8.
Sawhney P, Giammona CJ, Meistrich ML, Richburg JH. Cisplatininduced
long-term failure of spermatogenesis in adult C57/B1/6J
mice. J Androl 2005;26:136-45.
Khaleeluddin K, Santpur SR, Rajaram P, Durgamba KK. Clinical
trials in cases of oligozoospermia with Speman. Probe 1973;4:203.
Pardanani DS, Delima RJ, Rao RV, Vaze AY, Jayatilak PG, Sheth AR.
Study of the effects of Speman on semen quality in oligospermic
men. Ind J Surg 1976;38:34.
Dupont E, Labrie F, Luu-The V, Pelletier G. Ontogeny of 3β-hydroxy
steroid dehydrogenase/Δ5-Δ4isomerase (3β-HSD) in rat testis as
studied by immunocytochemistry. Anat Embryol (Berl) 1993;187:583-9.
Nalini B, Shenoy SK, Geetha B, Anuradha, Vijay KV. The role
of herbal drugs in infertile couples. Obstet Gynaecol Today
;8:281-7.
